| Corbin Charles Asbury, MD | |
|
325 N Commercial St, Neenah, WI 54956-2665 | |
| (920) 722-1583 | |
| (920) 722-7454 |
| Full Name | Corbin Charles Asbury |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 31 Years |
| Location | 325 N Commercial St, Neenah, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316923386 | NPI | - | NPPES |
| 34352600 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 45392 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Agnes Hospital | Fond du lac, WI | Hospital |
| Thedacare Regional Med Ctr - Neenah | Neenah, WI | Hospital |
| Waupun Memorial Hospital | Waupun, WI | Hospital |
| Ascension Ne Wisconsin - St Elizabeth Campus | Appleton, WI | Hospital |
| Ripon Medical Center | Ripon, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Radiology Associates Of The Fox Valley Sc | 0446152748 | 44 |
News Archive
The U.S. Food and Drug Administration today is announcing safety label changes for the cholesterol-lowering medication simvastatin because the highest approved dose-80 milligram (mg)-has been associated with an elevated risk of muscle injury or myopathy, particularly during the first 12 months of use.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has notified the Company that it is extending the Prescription Drug User Fee Act goal date for the Company's supplemental biologics license application for XIAFLEX (collagenase clostridium histolyticum) for the treatment of Peyronie's disease from September 6, 2013 to December 6, 2013.
Cosmetic face cream used by fashionable Roman women has been analysed by scientists at Bristol University, UK, and then reproduced.
Selexis SA, a global life science company with technologies for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins announced today that CSL Limited has entered a commercial license agreement with Selexis for the preclinical development of a therapeutic antibody anticipated to enter Phase I clinical trials in 2012.
People who have had a heart attack are likely to report having been in traffic shortly before their symptoms began, researchers reported at the American Heart Association's 49th Annual Conference on Cardiovascular Disease Epidemiology and Prevention.
› Verified 2 days ago
| Entity Name | Radiology Associates Of The Fox Valley Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477539443 PECOS PAC ID: 0446152748 Enrollment ID: O20040127000011 |
News Archive
The U.S. Food and Drug Administration today is announcing safety label changes for the cholesterol-lowering medication simvastatin because the highest approved dose-80 milligram (mg)-has been associated with an elevated risk of muscle injury or myopathy, particularly during the first 12 months of use.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has notified the Company that it is extending the Prescription Drug User Fee Act goal date for the Company's supplemental biologics license application for XIAFLEX (collagenase clostridium histolyticum) for the treatment of Peyronie's disease from September 6, 2013 to December 6, 2013.
Cosmetic face cream used by fashionable Roman women has been analysed by scientists at Bristol University, UK, and then reproduced.
Selexis SA, a global life science company with technologies for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins announced today that CSL Limited has entered a commercial license agreement with Selexis for the preclinical development of a therapeutic antibody anticipated to enter Phase I clinical trials in 2012.
People who have had a heart attack are likely to report having been in traffic shortly before their symptoms began, researchers reported at the American Heart Association's 49th Annual Conference on Cardiovascular Disease Epidemiology and Prevention.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Corbin Charles Asbury, MD 325 N Commercial St, Neenah, WI 54956-2665 Ph: (920) 722-1583 | Corbin Charles Asbury, MD 325 N Commercial St, Neenah, WI 54956-2665 Ph: (920) 722-1583 |
News Archive
The U.S. Food and Drug Administration today is announcing safety label changes for the cholesterol-lowering medication simvastatin because the highest approved dose-80 milligram (mg)-has been associated with an elevated risk of muscle injury or myopathy, particularly during the first 12 months of use.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has notified the Company that it is extending the Prescription Drug User Fee Act goal date for the Company's supplemental biologics license application for XIAFLEX (collagenase clostridium histolyticum) for the treatment of Peyronie's disease from September 6, 2013 to December 6, 2013.
Cosmetic face cream used by fashionable Roman women has been analysed by scientists at Bristol University, UK, and then reproduced.
Selexis SA, a global life science company with technologies for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins announced today that CSL Limited has entered a commercial license agreement with Selexis for the preclinical development of a therapeutic antibody anticipated to enter Phase I clinical trials in 2012.
People who have had a heart attack are likely to report having been in traffic shortly before their symptoms began, researchers reported at the American Heart Association's 49th Annual Conference on Cardiovascular Disease Epidemiology and Prevention.
› Verified 2 days ago
Paul A. Larson, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 325 N Commercial St, Neenah, WI 54956 Phone: 920-722-1583 Fax: 920-722-7454 | |
Timothy H. Seline, MD Radiology Medicare: Medicare Enrolled Practice Location: 325 N Commercial St, Neenah, WI 54956 Phone: 920-722-1583 Fax: 920-722-7454 | |
Katrina A. Rosculet, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 325 N Commercial St, Neenah, WI 54956 Phone: 920-722-1583 Fax: 920-722-7454 | |
Rudolph Y. Lin, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 325 N Commercial St, Neenah, WI 54956 Phone: 920-722-1583 Fax: 920-722-7454 | |
Audrey E Nolten, MD Radiology Medicare: Medicare Enrolled Practice Location: 325 N Commercial St, Neenah, WI 54956 Phone: 920-722-1583 Fax: 920-722-7454 | |
Hong Xie, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 333 N Commercial St, Neenah, WI 54956 Phone: 920-738-2000 | |
Dr. Bradley John Hartmann, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 333 N Commercial St Ste 100, Neenah, WI 54956 Phone: 920-722-1840 Fax: 414-259-9290 |